Antiplatelet treatment for acute secondary prevention of non-cardioembolic minor stroke / transient ischaemic attack: an update for the acute physician
Minhas, Jatinder S Robinson, Thompson Eveson, David Mistri, Amit Bath, Philip M. Sprigg, Nikola Krishnan, Kailash
Minhas, Jatinder S
Robinson, Thompson
Eveson, David
Mistri, Amit
Bath, Philip M.
Sprigg, Nikola
Krishnan, Kailash
Abstract
Acute stroke is the leading cause of disability in the UK and a leading cause of mortality worldwide. The majority of patients with ischaemic stroke present with minor deficits or transient ischaemic attack (TIA), and are often first seen by patient-facing clinicians. Urgent evaluation and treatment are important as many patients are at high risk of major vascular events and death within hours to days after the index event. This narrative review summarises the evidence on four antiplatelet treatments for non-cardioembolic stroke prevention: aspirin, clopidogrel, dipyridamole and ticagrelor. Each of these drugs has a unique mechanism and has been tested as a single agent or in combination. Aspirin, when given early is beneficial and short-term treatment with aspirin and clopidogrel has been shown to be more effective in high-risk TIA / minor stroke. This review concludes by highlighting gaps in evidence, including scope for future trials that could potentially change clinical practice.
MIDER Authors
Citations
Altmetric:
Date
2022-09
Type
Article
Subject
Antiplatelets, Recurrent stroke, Stroke prevention, Stroke risk, Transient ischaemic attack
Collections
Citation
Krishnan, K., Law, Z. K., Minhas, J. S., Bath, P. M., Robinson, T. G., Sprigg, N., Mavilakandy, A., England, T. J., Eveson, D., Mistri, A., Dawson, J., & Appleton, J. P. (2022). Antiplatelet treatment for acute secondary prevention of non-cardioembolic minor stroke / transient ischaemic attack: an update for the acute physician. Clinical medicine (London, England), 22(5), 449–454. https://doi.org/10.7861/clinmed.2021-0597